Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Citrulline | 10 | 2025 | 116 | 2.690 |
Why?
|
| Arginine | 9 | 2025 | 335 | 2.380 |
Why?
|
| Lactation | 9 | 2020 | 195 | 2.200 |
Why?
|
| Milk, Human | 10 | 2025 | 308 | 2.050 |
Why?
|
| Mammary Glands, Human | 4 | 2015 | 80 | 1.300 |
Why?
|
| Polyethylene Glycols | 3 | 2024 | 240 | 0.840 |
Why?
|
| Arginase | 2 | 2020 | 35 | 0.800 |
Why?
|
| Amino Acids | 3 | 2025 | 615 | 0.800 |
Why?
|
| Galactose | 2 | 2015 | 53 | 0.780 |
Why?
|
| Hydrolases | 3 | 2024 | 60 | 0.760 |
Why?
|
| Swine | 10 | 2025 | 1173 | 0.730 |
Why?
|
| Glutamine | 3 | 2024 | 196 | 0.680 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2020 | 236 | 0.660 |
Why?
|
| Glucose | 5 | 2015 | 839 | 0.650 |
Why?
|
| Jejunum | 1 | 2020 | 122 | 0.640 |
Why?
|
| Duodenum | 1 | 2020 | 110 | 0.640 |
Why?
|
| Gluconeogenesis | 3 | 2015 | 93 | 0.580 |
Why?
|
| Nutrigenomics | 1 | 2017 | 7 | 0.550 |
Why?
|
| Glycerol | 2 | 2015 | 80 | 0.530 |
Why?
|
| Aging | 2 | 2024 | 1207 | 0.510 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 218 | 0.500 |
Why?
|
| Lactose | 2 | 2020 | 53 | 0.490 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 979 | 0.490 |
Why?
|
| Blood Glucose | 5 | 2024 | 1081 | 0.480 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 754 | 0.470 |
Why?
|
| Lipids | 3 | 2013 | 551 | 0.460 |
Why?
|
| Lipogenesis | 2 | 2021 | 62 | 0.450 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2018 | 192 | 0.400 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 355 | 0.400 |
Why?
|
| Triglycerides | 3 | 2019 | 596 | 0.400 |
Why?
|
| MicroRNAs | 2 | 2017 | 872 | 0.400 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 107 | 0.390 |
Why?
|
| Uridine Diphosphate Galactose | 1 | 2012 | 6 | 0.380 |
Why?
|
| Fasting | 2 | 2014 | 300 | 0.370 |
Why?
|
| Animals, Newborn | 5 | 2025 | 1015 | 0.370 |
Why?
|
| Female | 29 | 2025 | 68770 | 0.360 |
Why?
|
| Animals | 22 | 2025 | 33208 | 0.350 |
Why?
|
| Insulin | 3 | 2010 | 1128 | 0.350 |
Why?
|
| Oligosaccharides | 2 | 2022 | 73 | 0.340 |
Why?
|
| Diabetes, Gestational | 1 | 2012 | 107 | 0.340 |
Why?
|
| Dietary Sucrose | 1 | 2010 | 41 | 0.330 |
Why?
|
| Epithelial Cells | 2 | 2020 | 873 | 0.330 |
Why?
|
| Enteral Nutrition | 2 | 2025 | 279 | 0.320 |
Why?
|
| Breast Feeding | 3 | 2020 | 226 | 0.320 |
Why?
|
| Premature Birth | 2 | 2025 | 404 | 0.290 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 2314 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 1357 | 0.290 |
Why?
|
| Cholestasis | 2 | 2021 | 166 | 0.280 |
Why?
|
| Caloric Restriction | 1 | 2009 | 98 | 0.280 |
Why?
|
| Insulin Resistance | 3 | 2024 | 665 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 4513 | 0.270 |
Why?
|
| Dietary Fats | 1 | 2009 | 271 | 0.270 |
Why?
|
| Lactobacillus acidophilus | 1 | 2006 | 2 | 0.260 |
Why?
|
| Methylmalonic Acid | 1 | 2006 | 15 | 0.260 |
Why?
|
| Vitamin B 12 | 1 | 2006 | 57 | 0.250 |
Why?
|
| Neuroblastoma | 2 | 2022 | 539 | 0.250 |
Why?
|
| Homocysteine | 1 | 2006 | 118 | 0.240 |
Why?
|
| Probiotics | 2 | 2020 | 222 | 0.240 |
Why?
|
| Fatty Acids | 2 | 2022 | 351 | 0.240 |
Why?
|
| Growth Disorders | 1 | 2007 | 183 | 0.240 |
Why?
|
| Social Class | 1 | 2007 | 206 | 0.240 |
Why?
|
| Dietary Supplements | 2 | 2025 | 440 | 0.230 |
Why?
|
| Infusions, Intravenous | 2 | 2018 | 537 | 0.230 |
Why?
|
| Weight Loss | 1 | 2009 | 503 | 0.230 |
Why?
|
| Male | 16 | 2024 | 62895 | 0.230 |
Why?
|
| Obesity | 3 | 2024 | 2338 | 0.220 |
Why?
|
| Population Surveillance | 1 | 2007 | 395 | 0.220 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2022 | 56 | 0.220 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2024 | 14 | 0.220 |
Why?
|
| Folic Acid | 1 | 2006 | 282 | 0.220 |
Why?
|
| Kinetics | 2 | 2021 | 1092 | 0.210 |
Why?
|
| Thermogenesis | 1 | 2024 | 50 | 0.210 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 85 | 0.210 |
Why?
|
| Carbon Isotopes | 2 | 2015 | 229 | 0.210 |
Why?
|
| Adult | 11 | 2024 | 30609 | 0.210 |
Why?
|
| Endotoxemia | 1 | 2024 | 54 | 0.210 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 88 | 0.210 |
Why?
|
| Energy Metabolism | 2 | 2024 | 762 | 0.210 |
Why?
|
| Parenteral Nutrition | 3 | 2021 | 214 | 0.200 |
Why?
|
| Biological Availability | 2 | 2021 | 137 | 0.200 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2025 | 252 | 0.190 |
Why?
|
| Kidney | 2 | 2019 | 1283 | 0.190 |
Why?
|
| Glycomics | 1 | 2021 | 15 | 0.180 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2021 | 17 | 0.180 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 30 | 0.180 |
Why?
|
| Humans | 25 | 2025 | 127511 | 0.170 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 1774 | 0.170 |
Why?
|
| Phytosterols | 1 | 2021 | 28 | 0.170 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 4445 | 0.170 |
Why?
|
| Propane | 1 | 2020 | 28 | 0.170 |
Why?
|
| Glyceraldehyde | 1 | 2020 | 28 | 0.170 |
Why?
|
| Polysaccharides | 1 | 2021 | 140 | 0.160 |
Why?
|
| Urea Cycle Disorders, Inborn | 2 | 2020 | 84 | 0.160 |
Why?
|
| Tissue Distribution | 1 | 2021 | 363 | 0.160 |
Why?
|
| Liver Glycogen | 1 | 2020 | 22 | 0.160 |
Why?
|
| Metagenome | 1 | 2020 | 142 | 0.160 |
Why?
|
| Diet | 3 | 2020 | 1105 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 973 | 0.150 |
Why?
|
| Argininosuccinate Lyase | 1 | 2020 | 65 | 0.150 |
Why?
|
| Synbiotics | 1 | 2019 | 5 | 0.150 |
Why?
|
| Nitrogen Isotopes | 1 | 2018 | 45 | 0.150 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2018 | 16 | 0.150 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 65 | 0.150 |
Why?
|
| Dipeptides | 1 | 2018 | 64 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2019 | 68 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2009 | 425 | 0.140 |
Why?
|
| Microbiota | 2 | 2020 | 426 | 0.140 |
Why?
|
| Endotoxins | 1 | 2018 | 50 | 0.140 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2019 | 59 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 243 | 0.140 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 1344 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 493 | 0.140 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 1286 | 0.140 |
Why?
|
| Mice | 8 | 2024 | 17693 | 0.140 |
Why?
|
| Benzoates | 1 | 2017 | 26 | 0.140 |
Why?
|
| Ethanol | 1 | 2019 | 159 | 0.130 |
Why?
|
| Lactic Acid | 2 | 2015 | 142 | 0.130 |
Why?
|
| Egypt | 2 | 2007 | 27 | 0.130 |
Why?
|
| Biological Transport | 2 | 2021 | 327 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3720 | 0.130 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 55 | 0.130 |
Why?
|
| Growth | 1 | 2017 | 92 | 0.130 |
Why?
|
| Transcriptome | 2 | 2014 | 1069 | 0.130 |
Why?
|
| Models, Animal | 1 | 2018 | 453 | 0.130 |
Why?
|
| Nutritional Requirements | 1 | 2017 | 160 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2020 | 381 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2017 | 314 | 0.120 |
Why?
|
| Cross-Over Studies | 2 | 2020 | 327 | 0.120 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 36 | 0.120 |
Why?
|
| Sodium Acetate | 1 | 2015 | 2 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2018 | 467 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2025 | 4489 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2015 | 44 | 0.110 |
Why?
|
| Isotope Labeling | 2 | 2018 | 93 | 0.110 |
Why?
|
| Genotype | 1 | 2020 | 2600 | 0.110 |
Why?
|
| Intestines | 1 | 2018 | 578 | 0.110 |
Why?
|
| Pyruvate Kinase | 1 | 2014 | 8 | 0.110 |
Why?
|
| Genes, Lethal | 1 | 2014 | 75 | 0.110 |
Why?
|
| Infant, Premature | 1 | 2019 | 829 | 0.100 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 84 | 0.100 |
Why?
|
| Research Design | 1 | 2017 | 694 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 137 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2015 | 205 | 0.100 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2014 | 84 | 0.100 |
Why?
|
| Pregnancy | 3 | 2019 | 7426 | 0.090 |
Why?
|
| Metabolism | 1 | 2012 | 42 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 239 | 0.090 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 168 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2014 | 307 | 0.090 |
Why?
|
| Eating | 1 | 2014 | 359 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 364 | 0.090 |
Why?
|
| Estradiol | 1 | 2014 | 477 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2012 | 225 | 0.090 |
Why?
|
| Hormones | 1 | 2012 | 165 | 0.090 |
Why?
|
| Protein Carbonylation | 1 | 2010 | 6 | 0.090 |
Why?
|
| Palmitic Acid | 1 | 2010 | 28 | 0.080 |
Why?
|
| Young Adult | 2 | 2017 | 9705 | 0.080 |
Why?
|
| Infant | 4 | 2022 | 12810 | 0.080 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 90 | 0.080 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 44 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 424 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2010 | 236 | 0.080 |
Why?
|
| Emulsions | 2 | 2021 | 69 | 0.080 |
Why?
|
| Soybean Oil | 2 | 2021 | 71 | 0.080 |
Why?
|
| Fish Oils | 2 | 2021 | 82 | 0.080 |
Why?
|
| Hexoses | 1 | 2009 | 10 | 0.080 |
Why?
|
| Ketone Bodies | 1 | 2009 | 38 | 0.080 |
Why?
|
| Lactates | 1 | 2009 | 78 | 0.080 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 63 | 0.080 |
Why?
|
| Glucagon | 1 | 2009 | 146 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 1206 | 0.080 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2009 | 112 | 0.080 |
Why?
|
| C-Peptide | 1 | 2009 | 93 | 0.080 |
Why?
|
| Diet, Reducing | 1 | 2009 | 88 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2009 | 212 | 0.070 |
Why?
|
| Models, Biological | 1 | 2012 | 1374 | 0.070 |
Why?
|
| Urea | 2 | 2018 | 224 | 0.070 |
Why?
|
| Breath Tests | 1 | 2007 | 182 | 0.060 |
Why?
|
| Yogurt | 1 | 2006 | 13 | 0.060 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2006 | 44 | 0.060 |
Why?
|
| Body Height | 1 | 2007 | 192 | 0.060 |
Why?
|
| Texas | 1 | 2015 | 3565 | 0.060 |
Why?
|
| Energy Intake | 1 | 2009 | 495 | 0.060 |
Why?
|
| Lung | 1 | 2014 | 1523 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2015 | 2345 | 0.060 |
Why?
|
| Liver | 3 | 2019 | 1765 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 561 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2020 | 757 | 0.060 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2025 | 167 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 1206 | 0.060 |
Why?
|
| Administration, Intravenous | 1 | 2025 | 165 | 0.060 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2024 | 6 | 0.060 |
Why?
|
| Mutation | 1 | 2018 | 5949 | 0.060 |
Why?
|
| Infant Formula | 1 | 2025 | 104 | 0.060 |
Why?
|
| Dioxoles | 1 | 2024 | 12 | 0.060 |
Why?
|
| Uncoupling Protein 1 | 1 | 2024 | 31 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 3503 | 0.050 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2024 | 72 | 0.050 |
Why?
|
| Body Weight | 1 | 2007 | 971 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2025 | 8371 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2024 | 200 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 291 | 0.050 |
Why?
|
| Gene Expression | 2 | 2019 | 1487 | 0.050 |
Why?
|
| Algorithms | 1 | 2009 | 1638 | 0.050 |
Why?
|
| Sex Factors | 2 | 2017 | 1315 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2022 | 26 | 0.050 |
Why?
|
| Fucosyltransferases | 1 | 2021 | 25 | 0.040 |
Why?
|
| Glycosylation | 1 | 2021 | 111 | 0.040 |
Why?
|
| Mucins | 1 | 2021 | 67 | 0.040 |
Why?
|
| ARNTL Transcription Factors | 1 | 2021 | 44 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 131 | 0.040 |
Why?
|
| Gangliosides | 1 | 2021 | 67 | 0.040 |
Why?
|
| Fluorocarbons | 1 | 2021 | 61 | 0.040 |
Why?
|
| Spores, Bacterial | 1 | 2020 | 23 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 120 | 0.040 |
Why?
|
| Erythropoietin | 1 | 2021 | 104 | 0.040 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2021 | 79 | 0.040 |
Why?
|
| Prevalence | 1 | 2007 | 2623 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 232 | 0.040 |
Why?
|
| Adolescent | 2 | 2024 | 20156 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 410 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 154 | 0.040 |
Why?
|
| Olive Oil | 1 | 2019 | 24 | 0.040 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2019 | 2 | 0.040 |
Why?
|
| Tight Junction Proteins | 1 | 2019 | 13 | 0.040 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Aldehydes | 1 | 2019 | 28 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 840 | 0.040 |
Why?
|
| Fermentation | 1 | 2019 | 66 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2020 | 299 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2019 | 41 | 0.040 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2018 | 35 | 0.040 |
Why?
|
| Argininosuccinate Synthase | 1 | 2018 | 25 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 3714 | 0.040 |
Why?
|
| Vasomotor System | 1 | 2018 | 19 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 64 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 1326 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 152 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 947 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 366 | 0.030 |
Why?
|
| Organoids | 1 | 2020 | 283 | 0.030 |
Why?
|
| Dysbiosis | 1 | 2019 | 138 | 0.030 |
Why?
|
| Weaning | 1 | 2017 | 48 | 0.030 |
Why?
|
| Nitrogen | 1 | 2017 | 122 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 149 | 0.030 |
Why?
|
| Inflammation | 1 | 2024 | 1434 | 0.030 |
Why?
|
| Child | 2 | 2007 | 25298 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 419 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 539 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 638 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 353 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1438 | 0.030 |
Why?
|
| Diet, Western | 1 | 2015 | 20 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1199 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 51 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 702 | 0.030 |
Why?
|
| Mitogens | 1 | 2014 | 30 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 103 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 192 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 1016 | 0.030 |
Why?
|
| Risk Factors | 1 | 2007 | 10636 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 303 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1232 | 0.020 |
Why?
|
| Weight Gain | 1 | 2015 | 377 | 0.020 |
Why?
|
| Cellular Reprogramming | 1 | 2014 | 107 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2015 | 476 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2014 | 296 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 691 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3253 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1759 | 0.020 |
Why?
|
| Estrogens | 1 | 2014 | 424 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 796 | 0.020 |
Why?
|
| Endometrium | 1 | 2014 | 269 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2006 | 12582 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 2311 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1382 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2519 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 900 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3051 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2400 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 27894 | 0.010 |
Why?
|